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Objective: To evaluate SLE patients who persistently frequent the ED to identify 
opportunities to improve outpatient care. 
Methods: We conducted a retrospective study of SLE patients who frequented the 
ED for ≥3 visits in a calendar year from 2013-2016. Persistent users met criteria for 
frequent use for at least 2 out of the 4 years, and limited users for 1 out of the 4 
years. Each ED encounter was categorized as; SLE-, infection-, pain- related, or 
“other”. We compared ED use between persistent and limited users, and analyzed 
factors associated with pain-related encounters among persistent users through 
multivariate logistic regression. 
Results: We identified 77 participants having 1143 encounters as persistent users, 
and 52 participants having 335 encounters as limited users. Persistent users 
accounted for 77% of ED use by SLE patients who frequented the ED. Pain-related 
ED visits were more common among persistent users (32%) than limited users 
(18%). Among persistent users, most pain-related encounters were discharged from 
the ED (69%) or within 48 hours of admission (20%). Persistent users with pain-
related encounters accounting for >10% of ED use, were more likely to be obese, 
have fewer comorbid conditions, and be on LTOT. 
Conclusion: Pain is major cause of ED use. SLE patients persistently utilizing the 
ED for pain are likely to be non-critically ill, as evidenced by frequent discharges 
from the ED and short stay admissions. SLE patients who persistently frequent the 
ED for pain represent a viable target for interventions to improve outpatient quality of 
care. 
 















This article is protected by copyright. All rights reserved 
 SLE is associated with substantial socioeconomic burden and healthcare 
resource utilization. SLE patients with low socioeconomic status, irrespective 
of their access to care, frequent the ED. This pattern of ED use suggests a 
gap in the care of SLE. 
 Increasingly it is recognized that frequent ED use is not a stable 
phenomenon. Most high-utilizers only experience a brief period of frequent 
ED use (<12months), however, a subgroup continue to frequent the ED over 
years. 
 Understanding persistently frequent ED use in SLE can help provide insight 
into opportunities to reduce health care resource utilization and improve 
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Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune 
disorder associated with substantial socioeconomic burden and healthcare resource 
utilization. Inpatient care accounts for the largest component of direct costs (1-4). 
However, SLE patients have more ED visits than hospital admissions, with 40-70% 
of SLE patients having at least one ED visit in a year (1-6). In addition, 
hospitalizations are increasingly originating from the ED (7), and approximately 20% 
of admissions of SLE patients are avoidable (8). For these reasons, understanding 
ED utilization among persons with SLE may provide insight into drivers of both 
healthcare resource utilization and poor quality of care for SLE in the outpatient 
setting. 
As in the general population, SLE patients with low socio-demographic status, 
lower education level, and poor adherence more frequently utilize the ED, and 
account for the majority of all ED visits (9). The definition of frequent ED use is 
variable but, frequent ED users generally account for 4.5 to 8% of all ED patients 
and 21 to 28% of all ED visits (10). Frequent ED use has been generally thought to 
arise from difficulty in access to primary or specialty care (11, 12). However, studies 
show that most frequent ED users have insurance coverage and are more likely to 
utilize all existing forms of healthcare resources including outpatient care (9, 10, 13-
15). In addition, there is evidence to suggest that the use of ED, for most people, is 
an affirmative choice over other sources of healthcare rather than a last resort (16). 
It is increasingly recognized that frequent ED users are not a homogenous 
population (10, 17, 18). In the general population, studies have demonstrated that 
most individuals cease to qualify as frequent ED users within a year (17, 19). This 
brief period of frequent ED use may be due to an acute event requiring multiple ED 
visits, pregnancy related complications, or flare of a chronic disease. In contrast, a 
small but consistent percentage persistently frequent the ED over years (17, 19). 
Causes, and therefore interventions, for this subgroup of patients are likely to be 
different than for those with a brief period of frequent ED use. Understanding the 
factors underlying persistently frequent ED use may help inform interventions to 
improve chronic disease management and care co-ordination in the outpatient 
setting. 
In this study, we sought to identify SLE patients who persistently frequented 
the ED over four years. We examined the characteristics and patterns of ED 
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answer the following questions: What are the demographic and disease 
characteristics of SLE patients who persistently frequent the ED? How do 
persistently frequent users compare to those with limited frequent ED use? Is 




We performed an electronic health record (EHR) based query in EPIC for a 
cohort where International Classification of Diseases (ICD), 10th
We then verified the diagnosis of SLE through in-depth EHR review. Only 
those who met American College of Rheumatology criteria for SLE (20), or had SLE 
documented by a rheumatologist, nephrologist, or dermatologist, or were on active 
immunosuppressive therapy treatment for no other medical condition, were 
determined to have a verified diagnosis of SLE and included in the study. 
 edition code of M32 
for SLE was entered at least once in either the problem list, encounter diagnosis or 
as a billing code during the study period between 1/1/2013 and 12/1/2016, and met 
criteria for persistently frequent ED use. Persistently frequent ED use was defined as 
having more than three ED visits during the 12 months in a calendar year, similar to 
previous studies on ED utilization among persons with SLE (9), for at least two out of 
the four years during the study period, consecutive or non-consecutive, between 
2013 and 2016, at a large urban tertiary medical center. 
For those diagnosed with SLE during the study period, we reviewed and 
censored ED encounters preceding diagnosis unless diagnosis of SLE was probable 
at the time of visit based on physician documentation and/or serologic work-up. We 
then re-evaluated the number of ED encounters for these newly diagnosed SLE 
patients to ensure they still met criteria for persistently frequent ED use after removal 
of censored visits. In instances of patient death prior to close of the study period, we 
reviewed the number of ED visits from study inception to time of death to ensure 
fulfillment of criteria for persistently frequent ED use. 
To understand the comparative magnitude and pattern of ED utilization 
among persistently frequent users, we performed a second EHR-based query and 
applied the same criteria to verify diagnosis of SLE and number of ED encounters to 
identify SLE patients who had limited frequent ED use. Limited use was defined as 
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The study protocol was approved by the Human Research Protection 
Program at our Institution. 
Data 
We collected patient- and encounter-level data through retrospective in-depth 
physician review of the EHR using a standardized data abstraction template. 
Patient-Level Measures 
We collected demographic information including age, gender, and 
race/ethnicity. Zip code information was collected to calculate the Area of Deprivation 
Index (ADI) (21). The ADI is a geographic area-based measure of socioeconomic 
deprivation (22). It combines 17 different indicators of SES, including level of 
education, income, employment, value of assets, and poverty level derived from 
decennial census data. Higher ADI values represent greater deprivation. We also 
queried the EHR for primary insurance coverage at time of enrollment, and 
categorized type of insurance as Medicaid, Medicare, or private/commercial. 
We collected information on SLE history, including manifestations, disease 
duration, and organ involvement prior to the index encounter through in-depth 
retrospective EHR review. For those with lupus nephritis (LN), we reviewed 
treatment history, and/or active renal replacement therapy through either 
hemodialysis or peritoneal dialysis, and/or transplant status. Information related to 
lupus disease activity at time of ED encounter was not consistently available in the 
EHR. We also collected medication history, including exposure to glucocorticoids 
(GC), hydroxychloroquine (HCQ), and/or additional disease modifying anti-rheumatic 
drugs (DMARDs) such as azathioprine, methotrexate, and mycophenolate mofetil. 
We categorized LTOT as having prescription for daily or near-daily use of opioids for 
at least 90 days, or total days of opioid supply for more than 120 days (23, 24). We 
also collected information on relevant medical comorbidities including depression. 
Encounter-Level Measures 
We classified disposition of each encounter as discharged from the ED or 
admitted to the hospital. For encounters resulting in ED-initiated admission, we 
obtained information on initial admission floor status (i.e. observation, 
medical/surgical floor, step down unit (SDU), intensive care unit (ICU)) and length of 
stay in the hospital (number of days). We categorized ED-initiated admissions 
without a claims code for ED critical care, not admitted to the SDU/ICU, and 
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 We categorized each ED encounter as: 1) SLE-related, 2) infection-related, 3) 
pain-related or 4) “other”. This categorization was applied after discharge, either from 
the ED or after ED-initiated admission. We classified encounters into one of these 
four groups based on the principle discharge diagnosis supported by physician 
documentation and diagnostic evaluation results. An encounter was classified as 
being SLE-related, if a patient presented with a SLE flare or SLE-related disease 
activity, and/or was prescribed GC, HCQ or other DMARD during the encounter by a 
rheumatologist, nephrologist or dermatologist. An encounter was classified as 
infection-related, if a patient had positive culture, or imaging diagnostic of infection, 
and received antibiotics in either the ED or on discharge. An encounter was 
classified as pain-related if the primary discharge diagnosis was for pain not 
attributable to SLE, trauma, or without a specific etiology or organic cause based on 
unremarkable diagnostic evaluation (e.g. no changes in electrocardiogram, no 
elevation in troponin, no abnormal imaging), and without indication for invasive or 
surgical intervention. By study definition, categories of SLE- and pain-related 
encounters were mutually exclusive. However, an encounter could be infection-
related and SLE- or pain-related. For those few cases (n= 8), the encounter was 
classified according to the principle discharge diagnosis. Encounters that were 
neither SLE-, infection-, or pain-related were classified as “other” (described in 
greater detail in Appendix 1, 2). 
Analyses 
Demographic, and disease characteristics were described using means, 
standard deviations (SDs), and proportions, as appropriate. We compared the 
distribution of encounters by category group at discharge from either the ED or after 
ED-initiated admission. In addition, for ED encounters that led to admission, we 
analyzed the length of stay and initial admission floor status to identify PASS 
admissions. 
We also compared sociodemographic and disease characteristics between 
SLE patients who persistently frequented to ED during the study period to those who 
had limited frequent ED use using t-test for continuous measures and Chi-square or 
Fisher’s exact for categorical measures. Variables with p-value <0.1 or with clinical 
significance were then included in a multivariate logistic regression model. The same 
analytic approach was conducted to assess factors related with higher propensity to 
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frequent the ED. We compared a group of persistent users who had pain-related 
encounters accounting for >10% of their total ED use to those for whom pain-related 




We initially identified 187 participants with possible SLE who met criteria for 
persistently frequent ED use and 132 that met criteria for limited frequent ED use 
from 2013-2016 through EHR query. After in-depth retrospective EHR review to 
verify diagnosis of SLE and censor ED encounters for date of SLE diagnosis and 
death, 77 and 52 SLE participants met all inclusion criteria for persistently and 
limited frequent ED use, respectively, during the study period (described in greater 
detail in Appendix 3). 
Overall (N=129), most of the participants were young African American 
female (n=77, 59.7%) with mean age 41.5 (SD 15.6). All had some form of insurance 
with most having Medicaid or Medicare as their primary coverage (n=106, 82.2%). 
ADI was higher compared to the region (mean 87.3, SD 26.7), reflecting higher 
neighborhood socioeconomic deprivation. Most were on GC (74.4%) and/or some 
form of DMARD (89.1%) during the study period. 
Characteristics for persistent and limited users are presented in Table 1. 
Approximately one in three persistent users (31.2%) and one in five limited users 
(19.2%) had diagnosis of depression. LTOT was nearly three times more prevalent 
among persistent users (37.7%) than limited users (13.5%). More persistent users 
had renal involvement on dialyses (19.5%) compared to limited users (5.8%). 
In multivariate analysis, SLE patients who persistently frequented the ED 
were more likely to be African American, have Medicare as their primary insurance 
coverage, be on dialysis, and be on LTOT, compared to those with limited frequent 
ED use (Table 2). 
ED Encounters in Persistent vs Limited Frequent Users 
The 77 SLE patients who persistently frequented the ED had 1143 ED 
encounters and the 52 patients with limited frequent ED use had 335 ED encounters. 
Persistent users had more than twice the average number of ED encounters (mean 
14.8, SD 8.8) compared to limited users (mean 6.4, SD 2.0) during the study period 
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that led to ED-initiated admission (48.6%) than limited users (39.7%) (p=0.004). 
More encounters were pain-related (32.4%) among persistent users compared to 
limited users (18.2%) (p<0.001). On average, persistent users had 4.8 pain-related 
encounters (SD 6.1) and limited users had 1.2 pain–related encounters (SD 1.4) 
during the study period (p<0.001). One in four persistent users (26%) had more than 
five pain-related encounters, whereas one single limited user (1.9%) had more than 
five pain-related encounters from 2013-2016 (p<0.001). Infection-related (12.9%) 
and SLE-related (6.7%) encounters were less common among persistently frequent 
users compared to limited users (15.5% and 10.5%, respectively). “Other” 
encounters accounted for the majority of ED use for persistent (48.0%) and limited 
(56%) users. 
ED Utilization among SLE patients who Persistently Frequent the ED 
 The 77 persistently frequent ED users accounted for 77% of all ED use by 
SLE patients who had 3 or more ED visits in a calendar year between 2013-2016. Of 
the 1143 encounters incurred by SLE patients who persistently frequented the ED, 
588 (51.4%) resulted in discharge from the ED and 555 (48.6%) led to ED-initiated 
admissions. A substantial portion of encounters resulting in discharge from the ED 
were pain-related (43.7%), some were infection-related (10.4%) and few were SLE-
related (1.4%) (Figure 1). The eight encounters categorized as SLE-related on 
discharge from the ED involved evaluation either by a rheumatologist or a 
nephrologist during the ED course, and had documentation to support findings of 
SLE-related activity/complications in the EHR. Among encounters resulting in ED-
initiated admission, 20.4% were pain-related, 15.5% were SLE-related and 12.4% 
were infection-related. 
Among encounters that led to ED-initiated admission, the majority (65.5%) of 
pain-related encounters resulted in admission with discharge within 48 hours and 
were significantly more likely than any other encounter category group to meet 
criteria for PASS admissions (p<0.001). Infection-related encounters were least likely 
to lead to admission with discharge within 48 hours (19.8%), and were more often 
initially admitted to the SDU/ICU (12.8%). In comparison, 43.5% of SLE-related 
encounters resulted in admissions with discharge within 48 hours. Among the 56.5% 
of SLE-related encounters resulting in ED-initiated admissions with a length of stay 
longer than 48 hours, 10.3% were initially to the SDU/ICU. 
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encounter category group varied. Thirty-two (41.6%) participants had one or more 
SLE-related encounters, and 55 (71.4%) and 61 (79.2%) participants had at least 
one infection- and pain-related encounter, respectively. All patients had at least one 
ED encounter classified as “other”. 
Patient Characteristics Associated with Pain-related Encounters among SLE 
patients who Persistently Frequent the ED 
 We observed a high burden of pain among SLE patients who persistently 
frequented the ED, with 50.7% of encounters coding pain as the chief complaint at 
initiation of the ED encounter. Pain was the presenting symptom for 51 (66.2%) of 
SLE-related, 38 (25.8%) of infection-related and 171 (31.1%) of “other” encounters. 
Of the 580 encounters with pain symptoms reported at presentation, 320 (55.2%) 
were categorized as pain-related encounters upon discharge. These pain-related 
encounters, as aforementioned, accounted for a third of ED use by SLE patients who 
persistently frequented the ED, representing 61 (79.2%) participants. We observed a 
wide range in the frequency of pain-related encounters among participants with at 
least one pain-related encounter. One participant had a single pain-related encounter, 
whereas another had 31 pain-related encounters during the study period. 
To understand factors associated with higher propensity to utilize the ED for 
pain, we compared characteristics of participants who had pain-related encounters 
accounting for >10% of their total ED use to those with pain-related encounters 
accounting for ≤10% of their total ED use (Table 3). Participants with higher 
propensity to persistently frequent the ED for pain-related encounters were younger 
(p=0.028), more likely to be African American (p=0.001), and come from more 
socioeconomically deprived neighborhoods (p=0.016). No difference in the 
prevalence of depression was observed, although, LTOT was more common in this 
group (p=0.040). In addition, participants with >10% pain-related encounters had 
fewer comorbid conditions (p=0.019) and were more likely to use DMARDs other 
than HCQ (p=0.041). In multivariate analysis, African Americans, fewer comorbid 
conditions, LTOT, and higher BMI were associated with higher propensity to utilize 
the ED for pain (Table 4). 
Characteristics of SLE patients who Persistently Frequent the ED with Pain-
Related PASS Admissions 
One in five hospitalized encounters were pain-related upon discharge from 
















This article is protected by copyright. All rights reserved 
which 74 (65.6%) encounters met criteria for PASS admissions. Table 5 describes 
the 25 (32.5%) participants who accounted for the 74 pain-related PASS admissions. 
All except one were female. The mean age was 38.4 years (SD 13.8); 18 (72%) 
were African American, 5 (20%) were Caucasian, and 2 (8%) were Hispanic. All had 
some form of insurance; 24 (96%) had public insurance, either Medicaid or Medicare, 
and only one subject (4%) had private/commercial insurance as their primary 
insurance. Of the 25 persistent users with pain-related PASS admissions, 13 (52.0%) 
were on LTOT. Even within this subgroup of participants, heterogeneity in the 
frequency of pain-related PASS admissions was observed. Fourteen (56%) 
participants had two or fewer pain related PASS admissions, whereas one 
participant accounted for 10 (13.5%) of these encounters. Overall, the 25 persistently 
frequent ED users with pain-related PASS admissions constituted a third of the study 
participants, and accounted for 43.8% of all ED encounters. 
To our knowledge, this is the first study to characterize persistently frequent 
ED use among SLE patients. In this study, SLE patients who frequented the ED were 
mostly young African American females all of whom had some form of insurance. 
Persistent users were more likely to have Medicare as their primary insurance and 
be on LTOT compared to limited users. Medicare was associated with persistent use 
when adjusted for age, and may be confounded by dialysis status and other factors 
unaccounted for in this study that relate to permanent disability or disability benefit 
status which are eligibility criteria for Medicare coverage. LTOT and depression were 
each observed in one in three SLE patients who persistently frequented the ED. 
Discussion 
In this study, persistent users disproportionately utilized the ED compared to 
limited users, and mostly for non-lupus related pain reasons. Chronic pain, a 
symptom frequently experienced by patients with SLE (25, 26), was a major cause of 
ED utilization and ED-initiated admissions among SLE patients who persistently 
frequented the ED. SLE patients persistently utilizing the ED for pain were more 
likely to be non-critically ill, as evidenced by frequent discharge from the ED and 
PASS admissions. And so, SLE patients who persistently frequent the ED for chronic 
pain represent a viable and high impact target for early intervention and education to 
improve chronic care management and coordination. 
Lessons on how to improve the delivery of care to SLE patients may be 
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share certain characteristics in that both are complex chronic diseases, with periods 
of exacerbation, which disproportionately affect young African Americans, and are 
frequently associated with chronic pain. Outpatient pain has been shown to be 
predictive of ED utilization among patients with sickle cell disease and intensive 
ambulatory management with frequent outpatient visits has been successful in 
reducing healthcare resource utilization (27-29). However, despite projected 
therapeutic efficacy and cost-effectiveness of ambulatory chronic pain management, 
compliance with and sustained improvement of healthcare resource utilization 
through nonpharmacological pain management may be challenging. Studies have 
identified poor social support and communication with providers, limitation of 
financial and transportation resources, reliance on opioids, lack of belief in, and 
inadequacy of pain control as barriers to multimodality pain management (30-33). 
For these reasons, and findings that regardless of access to care, some patients 
continue to preferentially utilize the ED for ambulatory care sensitive conditions such 
as chronic pain (16, 34, 35), ED-based interventions for chronic pain management, 
such as case management, use of chronic pain protocols, and pain specialist 
consultation in the ED, should be developed to complement outpatient services. 
Some studies have explored the use of individualized home pain management 
programs and community health workers who provide social support, navigation of 
health systems and resources, and counseling, for the management of chronic pain 
in sickle cell disease (36, 37). Web-based non-pharmacologic interventions may also 
be a viable option for chronic pain management in young SLE patients, with ready 
access to and familiarity with technology, but often with limited access to outpatient 
specialty pain clinics (38-41). 
This study has several limitations. Findings are based on a small number of 
participants at a single tertiary medical center. The cohort of SLE patients who 
persistently frequented the ED, however, is expected to be small as frequent ED 
users typically consist of 4.5-8% of all ED patients, and persistently frequent ED 
users are a smaller subgroup of this population (10, 17). In addition, the criteria to 
confirm diagnosis of SLE was designed to have high specificity for this study, further 
limiting the size of the cohort. Utilization of validated EHR based search algorithms 
with high positive predictive value to identify SLE patients in future studies would 
increase both generalizability and reproducibility. Although based on a small cohort, 
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unique ED encounters, and detailed information on patient and encounter level 
variables for each visit that were obtained through retrospective in-depth physician 
chart review. However, because data on lupus-related disease activity either through 
validated or laboratory measures at time of each ED encounter were not consistently 
available, we were unable to assess the relationship between SLE-disease activity, 
pain and ED utilization. Findings from this study would be strengthened by 
conducting key informant qualitative interviews. SLE patients who persistently 
frequent the ED can be engaged to elicit their perception of, and barriers to, 
ambulatory care coordination and, as relevant, chronic pain management. Clinical 
impression at time of care transition from the ED and factors influencing physician 
decision for admissions can inform understanding of ED-initiated admissions. In this 
study, ED encounters were categorized using a priori criteria based on the principle 
discharge diagnosis. Further delineation of “other” encounters, particularly those that 
led to ED-initiated admission and were more likely to have greater complexity and 
discharge diagnosis codes, may provide further insight into the burden of pain not 
attributable to lupus and persistently frequent ED utilization. In addition, information 
on healthcare resource utilization during admission, especially during the first 48 
hours, would allow for factors associated with PASS admissions to be ascertained, 
and should be included in future studies to inform opportunities to reduce ED-
initiated admission of non-critically ill SLE patients and improve outpatient chronic 
disease management. 
In conclusion, SLE patients who persistently frequented the ED were young 
African American females, living in more economically deprived areas, with a high 
burden of depression and LTOT. Pain was a major cause of both ED utilization and 
ED-initiated admissions, most of which were PASS admissions. SLE patients who 
persistently frequent the ED, particularly for pain, would benefit from targeted early 
interventions, in both the ED and outpatient settings, to improve chronic disease 
management and care co-ordination. 
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Figure 1 Proportion of ED encounters in each encounter category group at discharge from either the 




Table 1 Demographics and disease characteristics of SLE patients who were limited and persistently 
frequent ED users between 2013 and 2016 
Variables Persistently 














SLE-related Infection-related Pain-related "Other" 
Encounter category group at discharge from ED 
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Demographics 
   Age, mean years (SD) 
   Female, n (%) 
   Race, n (%) 
Caucasian 
African American 
      Hispanic/Latino 
   Insurance, n (%) 
      Medicaid 
      Medicare 
      Private/Commercial 






































   Psychiatric diagnosis, n (%) 
Depression, n (%) 
Hypertension, n (%) 
   Hyperlipidemia, n (%) 
   Diabetes, n (%) 
   Coronary Artery Disease, n (%) 
   Cardiovascular Accident, n (%) 
   Congestive Heart Failure, n (%) 
   Asthma, n (%) 
 Chronic Obstructive Pulmonary Disease, n 
(%) 





































Body Mass Index, mean (SD) 30.4 (9.8) 29.5 (7.4)  0.584 
Long-term opioid therapy, n (%) 29 (37.7) 7 (13.5)  0.003 
SLE Disease Characteristics, n (%) 
   Disease duration ≥ 10 years 
   Renal Involvement 
      Lupus Nephritis on Dialyses 
      Lupus Nephritis with Transplant 
   Lung Involvement 
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Medication Use 
   None, n (%) 
   Glucocorticoids, n (%) 
   Hydroxychloroquine, n (%) 
   Other DMARD*, n (%) 



























*sum of number of participants on Azathioprine, Methotrexate and MMF exceed number of participants on 
other DMARD, as some were concomitantly on more than one DMARD; SD=standard deviation, No. of co-
morbidities=number of co-morbidities, Other DMARD=disease modifying antirheumatic drug (exclude HCQ) 
 
Table 2 Factors associated with persistently frequent ED use compared to limited frequent ED use 
Variable OR (95% CI) p-value 
Age 0.99 (0.96-1.03) 0.966 
Female 1.67 (0.40-7.03) 0.482 
Race 
   Caucasian 
   African American 










   Medicaid 
   Medicare 









Number of co-morbidities 0.70 (0.48-1.01) 0.061 
Depression 1.97 (0.66-5.82) 0.222 
Long-term opioid therapy 3.09 (1.02-9.38) 0.046† 
Renal Involvement on Dialysis 5.03 (1.06-23.84) 0.042† 
Other DMARD 0.44 (0.18-1.08) 0.075 
Other DMARD=disease modifying antirheumatic drug (exclude HCQ) 
        †statistically significant with p-value<0.05 
Table 3 Comparison of patient characteristics with various degrees of pain-related encounters among 
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Variables 
Percentage of Pain-related ED Encounters 
≤10%  >10%  p-value 
Number of participants 24 53  
Percentage of participants, % 31.2 68.8  
Demographics 
   Age, mean years (SD) 
   Female, n (%) 
   Race, n (%) 
      Caucasian 
      African American 
      Hispanic/Latino 
   Insurance, n (%) 
      Medicaid 
      Medicare  
      Private/Commercial 
Area of Deprivation Index, mean (SD) 
 
48.0 (18.4) 


































Co-morbidities   
Hypertension, n (%) 
Hyperlipidemia, n (%) 
Diabetes, n (%) 
  Coronary Artery Disease, n (%) 
  Congestive Heart Failure, n (%) 
   Cerebrovascular Accident, n (%) 
Chronic Obstructive Pulmonary Disease, n (%) 
Asthma, n (%) 































Depression, n (%) 10 (41.7) 14 (26.4) 0.181 
Long-term opioid therapy, n (%) 5 (20.8) 24 (45.3) 0.040 
Body Mass Index, mean (SD) 27.3 (6.9) 31.8 (10.6) 0.058 
SLE Disease Characteristics, n (%) 
   Disease Duration ≥ 10years 
   Renal Involvement 
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SD=standard deviation, No. of co-morbidities=number of co-morbidities, Other DMARD=disease modifying 
antirheumatic drug (other than HCQ) 
Table 4 Patient characteristics associated with higher propensity to utilize the ED for pain among SLE 













      Lupus Nephritis with Transplant 1 (7.7) 5 (23.8) 0.237 
Medication Use n (%) 
   Glucocorticoids  
   Hydroxychloroquine  













Variables OR (95% CI) p-value 













Area of Deprivation Index 1.05 (0.98-1.12) 0.201 
No. of co-morbidities 0.54 (0.33-0.89) 0.015 
Long-term opioid therapy 7.50 (1.19-47.43) 0.032 
Body Mass Index 





OR-=odds ratio, 95% CI=95% confidence interval, No. of co-morbidities=number of 
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Table 5 Characteristics of 25 persistently frequent ED user with pain-related PASS admissions and their pattern of ED utilization during the study period 
Patient 
ID 
Age Sex Race/ 
Ethnicity 


















P01 22 Female AA Medicaid 108.73 Yes 1 31 11 1 5 16 
P02 21 Female AA Medicaid 107.47 Yes 9 41 1 1 26 13 
P03 46 Female AA Medicaid 115.60 Yes 1 17 2 2 12 1 
P08 33 Female AA Medicare 114.64 Yes 2 11 1 0 3 7 
P09 36 Male AA Medicare 115.60 Yes 5 31 7 0 23 1 
P10 28 Female AA Medicaid 109.07 Yes 4 37 2 1 15 19 
P15 51 Female AA Medicaid 108.24 No 5 12 0 1 9 2 
P16 22 Female AA Medicare 126.32 No 1 18 1 4 3 10 
P21 36 Female AA Medicaid 111.65 No 3 11 2 1 5 3 
P23 44 Female Hispanic Medicaid 96.64 No 1 10 1 2 1 6 
P26 36 Female Caucasian Medicaid 89.39 Yes 10 42 0 1 32 9 
P27 22 Female AA Medicaid 103.25 No 1 13 2 1 9 1 
P29 27 Female AA Medicaid 86.08 No 3 21 2 6 12 1 
P32 39 Female AA Medicaid 116.35 No 1 10 0 4 3 3 
P34 67 Female AA Medicare 102.61 No 2 11 0 0 9 2 
P36 37 Female AA Medicare 126.82 No 2 10 0 3 5 2 
P43 48 Female Caucasian Medicaid 108.86 Yes 4 19 2 3 11 3 
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P49 60 Female Caucasian Medicare 81.76 Yes 1 11 0 3 4 4 
P54 72 Female AA Medicare 116.71 Yes 1 7 0 0 4 3 
P58 47 Female AA Private/Commercial 97.76 No 1 10 0 1 3 6 
P62 32 Female AA Medicaid 112.22 Yes 1 19 2 0 10 7 
P65 30 Female Hispanic Medicaid 115.60 No 1 9 0 0 6 3 
P69 24 Female Caucasian Medicare 109.09 Yes 4 49 0 6 8 35 
P73 40 Female Caucasian Medicare 101.70 No 4 29 5 3 17 4 
 AA=African American, ADI=Area of Deprivation Index, LTOT=long-term opioid therapy, No. Pain PASS=number of pain related potentially avoidable short stay admissions, 
No. SLE-related= number of SLE-related encounters, No. Infection-related= number of infection-related encounters, No. Pain-related= number of pain-related encounters, 
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Appendix 1 Criteria for categorizatioﾐ of さotherざ visits iﾐto differeﾐt ﾏedical specialties accordiﾐg to 
the principle discharge diagnosis of the encounter 
Medical Specialty Encounter Categorization Criteria 
Allergy Encounters due to allergic reactions such as hives, urticaria or 
angioedema 
Cardiology Encounters related to cardiac disorders which were not attributed to 
SLE such as arrhythmia, myocardial infarction, or congestive heart 
failure  
Dermatology Encounters primarily due to burns or skin lesions which were not 
attributed to SLE. 
Endocrinology Encounters related to glycemic control, or other hormonal 
dysfunction such as hypothyroidism/hyperthyroidism 
Gastroenterology Encounters related to gastrointestinal disorders such as gastritis, 
ulcers, pancreatitis, obstruction, hepatitis etc., not attributable to SLE 
General Internal Medicine Encounters due to hyper- or hypotension and other types of 
encounters that could not be clearly categorized into one of the 
thirteen other medical specialty groups, for example encounters for 
medication refill, abnormal labs, and dental issues 
Hematology Encounters related to hematopoietic dysfunction or thromboembolic 
event not attributable to SLE or antiphospholipid syndrome (APS)  
Nephrology Encounters due to acute or chronic kidney disease, unrelated to LN, 
with documentation from nephrology or pathology results 
Neurology Encounters of disorder of the nervous system such as seizures, CVA, 
or altered mental status not attributable to SLE 
Obstetrics/Gynecology Encounters due to pregnancy complications or other gynecologic 
issues not attributable to APS 
Psychiatry Encounters due to suicidal or homicidal ideation, alcohol intoxication, 
substance abuse or mood disorders not attributable to SLE  
Pulmonology Encounters due to respiratory disorders such as asthma, COPD, 
respiratory failure, not attributable to SLE  
Surgery Encounters that primarily required surgical intervention except for 
transplant due to LN  
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mechanical injury 
 
Appendix 2 Categorization of other ED encounters based on primary discharge diagnosis 
Medical Specialty 
Other ED encounter by 
Persistently Frequent ED 
users, n (%) 
 (n=549) 
Other ED encounter by 
Limited Frequent ED users, n 
(%) 
 (n=190) 
Allergy 14 (2.6) 7 (3.7) 
Cardiology  30 (5.5) 5 (2.6) 
Dermatology 28 (5.1) 7 (3.7) 
Endocrinology 9 (1.6) 5 (2.6) 
Gastroenterology 65 (11.8) 19 (10.0) 
General Internal Medicine 91 (16.6) 53 (27.9) 
Hematology 30 (5.5) 8 (4.2) 
Nephrology 24 (4.4) 8 (4.2) 
Neurology 50 (9.1) 18 (9.5) 
Obstetrics/Gynecology 72 (13.1) 14 (7.4) 
Psychiatry 27 (4.9) 1 (0.5) 
Pulmonology 64 (11.7) 19 (10.0) 
Surgery 13 (2.4) 1 (0.5) 
Trauma 32 (5.8) 25 (13.2) 
 
 
Appendix 3 Characteristics of SLE patients who had limited frequent ED use during 2013-2016 
Selection of SLE patients who persistently frequented the ED 
We initially identified 187 participants with possible SLE who met criteria for persistently 
frequent ED use and 132 that met criteria for limited ED use from 2013-2016 through EHR query. 
After in-depth retrospective EHR review, 83 had a diagnosis of SLE based on one of the four pre-
defined criteria. Ten participants were diagnosed with SLE during the study period and, after 
censoring for ED encounters where diagnoses of SLE was not probable, six were excluded. Four 
patients died during the study period, but all remained in the study, as each met the definition of 
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frequented the ED from 2013-2016 consisted of 77 participants. Diagnosis of SLE was verified based 
on documentation of SLE by a rheumatologist for 72 participants, and biopsy proven LN by a 
nephrologist for four participants. One participant, who met diagnosis of SLE based on ACR criteria 
had thrombosis in the setting of a positive lupus anticoagulant. 
 
Selection of SLE patients who had limited frequent ED use 
We initially identified 132 participants with possible SLE who met criteria for limited 
frequent ED use from 2013-2016 through EHR query. After in-depth retrospective EHR review, 59 had 
a diagnosis of SLE based on one of the four pre-defined criteria. Seven participants were diagnosed 
with SLE during the study period and, after censoring for ED encounters where diagnoses of SLE was 
not probable, all were excluded. No patients died during the study period. The final cohort of SLE 
patients who had limited frequent ED use from 2013-2016 consisted of 52 participants. Diagnosis of 
SLE was verified based on documentation of SLE by a rheumatologist for 48 participants, and biopsy 
proven LN by a nephrologist for four participants.  
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